Prof. Dr. dr. Hindra Irawan Satari, Sp.A(K), MTropPaed
Medical Advisor - Investigator
- Infection prevention and control in Indonesian hospitals: identification of strengths, gaps, and challenges
https://link.springer.com/article/10.1186/s13756-023-01211-5 - A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2--11 years: a phase II preliminary report
https://link.springer.com/article/10.1186/s12887-020-02375-4 - Safety profile of inactivated COVID-19 in healthy adults aged ≥ 18 years: A passive surveillance in Indonesia
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0286484 - One-month follow up of a randomized clinical trial-phase II study in 6 to <24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate Vaccine
https://www.sciencedirect.com/science/article/pii/S1201971220300485 - Immunogenicity and Safety of Half-Dose Heterologous mRNA-1273 Booster Vaccination for Adults Primed with the CoronaVac® and ChAdOx1-S Vaccines for SARS-CoV-2
https://www.mdpi.com/2076-393X/12/4/344